TRLCX
Price
$22.94
Change
+$0.23 (+1.01%)
Updated
Jun 6 closing price
Net Assets
6.32B
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

TRLCX vs VIVAX

Header iconTRLCX vs VIVAX Comparison
Open Charts TRLCX vs VIVAXBanner chart's image
Nuveen Large Cap Value Retire
Price$22.94
Change+$0.23 (+1.01%)
VolumeN/A
Net Assets6.32B
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
TRLCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TRLCX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRLCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. TRLCX (6.32B). VIVAX pays higher dividends than TRLCX: VIVAX (2.16) vs TRLCX (1.23). TRLCX was incepted earlier than VIVAX: TRLCX (23 years) vs VIVAX (33 years). TRLCX (0.66) is less costly to investors than VIVAX (0.17). TRLCX is a more actively managed with annual turnover of: 19.00 vs. VIVAX (9.00). TRLCX has a lower initial minimum investment than VIVAX: TRLCX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. TRLCX (6.41). VIVAX return over 5 years is better than : 58.70 vs. TRLCX (44.59).
TRLCXVIVAXTRLCX / VIVAX
Total Expense Ratio0.660.17388%
Annual Report Gross Expense Ratio0.660.17388%
Fund Existence23 years33 years-
Gain YTD3.3211.238268%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.32B189B3%
Annual Yield % from dividends1.232.1657%
Returns for 1 year6.416.8194%
Returns for 3 years13.6918.5174%
Returns for 5 years44.5958.7076%
Returns for 10 years33.35102.9032%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc